Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
Select Medical sees FY20 adjusted EPS $1.61-$1.71, consensus $1.40 » 16:34
10/29/20
10/29
16:34
10/29/20
16:34
SEM

Select Medical

$22.01 /

+0.61 (+2.85%)

Sees FY20 revenue…

Sees FY20 revenue $5.44B-$5.5B, consensus $5.41B. Sees FY20 adjusted EBITDA $745M-$765M.

ShowHide Related Items >><<
SEM Select Medical
$22.01 /

+0.61 (+2.85%)

SEM Select Medical
$22.01 /

+0.61 (+2.85%)

08/04/20 Deutsche Bank
Select Medical price target raised to $26 from $24 at Deutsche Bank
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
05/04/20 Wells Fargo
Select Medical price target lowered to $24 from $31 at Wells Fargo
SEM Select Medical
$22.01 /

+0.61 (+2.85%)

Earnings
Select Medical reports Q3 adjusted EPS 56c, consensus 29c » 16:32
10/29/20
10/29
16:32
10/29/20
16:32
SEM

Select Medical

$22.01 /

+0.61 (+2.85%)

Reports Q3 revenue…

Reports Q3 revenue $1.42B, consensus $1.37B.

ShowHide Related Items >><<
SEM Select Medical
$22.01 /

+0.61 (+2.85%)

SEM Select Medical
$22.01 /

+0.61 (+2.85%)

08/04/20 Deutsche Bank
Select Medical price target raised to $26 from $24 at Deutsche Bank
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
05/04/20 Wells Fargo
Select Medical price target lowered to $24 from $31 at Wells Fargo
SEM Select Medical
$22.01 /

+0.61 (+2.85%)

Over a month ago
Hot Stocks
Select Medical, RUSH enter JV to operate Illinois rehabilition centers » 13:31
09/24/20
09/24
13:31
09/24/20
13:31
SEM

Select Medical

$19.09 /

+0.62 (+3.36%)

Select Medical…

Select Medical Corporation announced a joint venture agreement with Rush University System for Health to manage operations of a critical illness recovery hospital, inpatient rehabilitation hospital and 63 physical therapy centers throughout the greater Chicago and Northwest Indiana region. Select Medical will serve as both the majority owner and managing partner across the three post-acute care lines. The agreement also includes the construction of a new state-of-the-art 84-bed hospital at Rush University Medical Center on Chicago's West Side, with 30 beds dedicated to critical illness recovery and 54 beds for inpatient rehabilitation. Anticipated completion of the new facility, which will be named Rush Specialty Hospital, is 2022. In the interim, Select Medical will manage the existing Rush Rehabilitation unit located in the Johnston R. Bowman Health Center on the Medical Center campus. Under the agreement, the combined outpatient rehabilitation centers contributed to the joint venture include 62 NovaCare Rehabilitation, Select Physical Therapy and Michiana Orthopaedic & Sports Physical Therapy locations from Select Medical, as well as the Rush Rehabilitation center. All 63 outpatient centers will be rebranded as RUSH Physical Therapy

ShowHide Related Items >><<
SEM Select Medical
$19.09 /

+0.62 (+3.36%)

SEM Select Medical
$19.09 /

+0.62 (+3.36%)

08/04/20 Deutsche Bank
Select Medical price target raised to $26 from $24 at Deutsche Bank
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
05/04/20 Wells Fargo
Select Medical price target lowered to $24 from $31 at Wells Fargo
SEM Select Medical
$19.09 /

+0.62 (+3.36%)

Conference/Events
Wells Fargo to hold a virtual conference » 04:55
09/10/20
09/10
04:55
09/10/20
04:55
INSP

Inspire Medical

$120.82 /

+3.19 (+2.71%)

, ICLR

Icon

$180.39 /

+3.92 (+2.22%)

, IMMU

Acquired by GILD

$42.25 /

+1.71 (+4.22%)

, CYAD

Celyad

$9.99 /

+ (+0.00%)

, HALO

Halozyme

$28.04 /

+0.29 (+1.05%)

, TCON

Tracon Pharmaceuticals

$3.56 /

-0.18 (-4.81%)

, ZYME

Zymeworks

$31.46 /

+0.225 (+0.72%)

, IRWD

Ironwood

$9.88 /

+0.17 (+1.75%)

, ICPT

Intercept

$44.54 /

+0.53 (+1.20%)

, BLCM

Bellicum Pharmaceuticals

$5.33 /

+0.11 (+2.11%)

, TFX

Teleflex

$389.99 /

+7.865 (+2.06%)

, TECH

Bio-Techne

$250.24 /

+4.44 (+1.81%)

, NVRO

Nevro

$138.42 /

+3.64 (+2.70%)

, SUPN

Supernus

$21.14 /

+0.28 (+1.34%)

, NARI

Inari Medical

$71.01 /

+1.29 (+1.85%)

, KZR

Kezar Life Sciences

$4.64 /

-0.06 (-1.28%)

, HOLX

Hologic

$59.21 /

+1.58 (+2.74%)

, MYOK

MyoKardia

$110.51 /

+3.205 (+2.99%)

, PINC

Premier

$32.60 /

+0.42 (+1.31%)

, UHS

Universal Health

$111.30 /

+1.98 (+1.81%)

, JNCE

Jounce Therapeutics

$7.89 /

+0.42 (+5.62%)

, JNJ

Johnson & Johnson

$149.80 /

+2.56 (+1.74%)

, GBT

Global Blood Therapeutics

$57.82 /

-0.92 (-1.57%)

, MDT

Medtronic

$106.65 /

+2.18 (+2.09%)

, RNA

Avidity Biosciences

$33.12 /

+2.73 (+8.98%)

, SEM

Select Medical

$19.92 /

+0.16 (+0.81%)

Healthcare Virtual…

Healthcare Virtual Conference will be held on September 9-10. Webcast Link

ShowHide Related Items >><<
ZYME Zymeworks
$31.46 /

+0.225 (+0.72%)

UHS Universal Health
$111.30 /

+1.98 (+1.81%)

TFX Teleflex
$389.99 /

+7.865 (+2.06%)

TECH Bio-Techne
$250.24 /

+4.44 (+1.81%)

TCON Tracon Pharmaceuticals
$3.56 /

-0.18 (-4.81%)

SUPN Supernus
$21.14 /

+0.28 (+1.34%)

SEM Select Medical
$19.92 /

+0.16 (+0.81%)

RNA Avidity Biosciences
$33.12 /

+2.73 (+8.98%)

PINC Premier
$32.60 /

+0.42 (+1.31%)

NVRO Nevro
$138.42 /

+3.64 (+2.70%)

MYOK MyoKardia
$110.51 /

+3.205 (+2.99%)

MDT Medtronic
$106.65 /

+2.18 (+2.09%)

KZR Kezar Life Sciences
$4.64 /

-0.06 (-1.28%)

JNJ Johnson & Johnson
$149.80 /

+2.56 (+1.74%)

JNCE Jounce Therapeutics
$7.89 /

+0.42 (+5.62%)

IRWD Ironwood
$9.88 /

+0.17 (+1.75%)

INSP Inspire Medical
$120.82 /

+3.19 (+2.71%)

IMMU Acquired by GILD
$42.25 /

+1.71 (+4.22%)

ICPT Intercept
$44.54 /

+0.53 (+1.20%)

ICLR Icon
$180.39 /

+3.92 (+2.22%)

HOLX Hologic
$59.21 /

+1.58 (+2.74%)

HALO Halozyme
$28.04 /

+0.29 (+1.05%)

GBT Global Blood Therapeutics
$57.82 /

-0.92 (-1.57%)

CYAD Celyad
$9.99 /

+ (+0.00%)

BLCM Bellicum Pharmaceuticals
$5.33 /

+0.11 (+2.11%)

INSP Inspire Medical
$120.82 /

+3.19 (+2.71%)

09/09/20 SVB Leerink
Inspire Medical price target raised to $150 from $120 at SVB Leerink
09/01/20 Baird
Inspire Medical initiated with an Outperform at Baird
08/21/20 Stifel
Inspire Medical price target raised to $125 from $110 at Stifel
08/06/20 Wells Fargo
Inspire Medical price target raised to $125 from $115 at Wells Fargo
ICLR Icon
$180.39 /

+3.92 (+2.22%)

07/27/20 Truist
SunTrust raises price targets on select late-stage CROs
07/27/20 Deutsche Bank
Icon price target raised to $170 from $135 at Deutsche Bank
07/27/20 Mizuho
Icon price target raised to $195 from $170 at Mizuho
07/24/20 BofA
Icon downgraded to Neutral from Buy at BofA
IMMU Acquired by GILD
$42.25 /

+1.71 (+4.22%)

08/17/20 Cowen
Immunomedics should have sufficient capacity to supply Trodelvy, says Cowen
08/05/20 Piper Sandler
Immunomedics price target raised to $60 from $55 at Piper Sandler
08/03/20 Piper Sandler
Immunomedics launch looks 'very favorable,' says Piper Sandler
07/27/20 Jefferies
Immunomedics price target raised to $55 after doctor survey at Jefferies
CYAD Celyad
$9.99 /

+ (+0.00%)

03/26/20 Wells Fargo
Celyad price target lowered to $20 from $44 at Wells Fargo
03/25/20 H.C. Wainwright
Celyad price target lowered to $37 from $43 at H.C. Wainwright
HALO Halozyme
$28.04 /

+0.29 (+1.05%)

08/11/20 BMO Capital
Halozyme price target raised to $43 from $35 at BMO Capital
08/11/20 Wells Fargo
Halozyme price target raised to $39 from $31 at Wells Fargo
07/02/20 Piper Sandler
Halozyme price target raised to $31 from $28 at Piper Sandler
07/01/20 Benchmark
Benchmark starts Halozyme at Buy with $39 price target
TCON Tracon Pharmaceuticals
$3.56 /

-0.18 (-4.81%)

04/24/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $4 from $6 at H.C. Wainwright
03/10/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $6 from $13 at H.C. Wainwright
02/28/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $13 from $18 at H.C. Wainwright
12/23/19 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $18 from $15 at H.C. Wainwright
ZYME Zymeworks
$31.46 /

+0.225 (+0.72%)

08/06/20
Fly Intel: Top analyst initiations
08/06/20 SVB Leerink
SVB Leerink bullish on Zymeworks, initiates with an Outperform
08/06/20 SVB Leerink
Zymeworks initiated with an Outperform at SVB Leerink
07/14/20 Guggenheim
Zymeworks price target lowered to $48, removed as Best Idea at Guggenheim
IRWD Ironwood
$9.88 /

+0.17 (+1.75%)

06/17/20 Northland
Northland starts Ironwood at Outperform, sees long runway for Linzess
06/17/20 Northland
Ironwood initiated with an Outperform at Northland
ICPT Intercept
$44.54 /

+0.53 (+1.20%)

09/09/20 B. Riley Securities
CymaBay price target raised to $13 from $9 at B. Riley FBR
09/02/20 Piper Sandler
Intercept workforce cut not related to potential approval, says Piper Sandler
08/28/20 Piper Sandler
Piper says Intercept data continues to tilt risk/benefit argument raised in CRL
08/27/20 Piper Sandler
Intercept's OCA 'comes out on top' at EASL, says Piper Sandler
BLCM Bellicum Pharmaceuticals
$5.33 /

+0.11 (+2.11%)

03/13/20 Raymond James
Bellicum Pharmaceuticals price target lowered to $17 from $40 at Raymond James
02/14/20 Wells Fargo
Bellicum Pharmaceuticals price target raised to $18 from $4 at Wells Fargo
01/24/20 Ladenburg
Bellicum pancreatic cancer data showed 'robust expansion,' says Ladenburg
TFX Teleflex
$389.99 /

+7.865 (+2.06%)

08/03/20 Piper Sandler
Teleflex approval for Urolift 2 earlier than expected, says Piper Sandler
07/30/20 Piper Sandler
Teleflex selloff on DOJ investigation should be bought, says Piper Sandler
06/09/20 Wells Fargo
Teleflex price target raised to $425 from $375 at Wells Fargo
06/04/20 SVB Leerink
Teleflex price target raised to $425 from $400 at SVB Leerink
TECH Bio-Techne
$250.24 /

+4.44 (+1.81%)

08/05/20 SVB Leerink
Bio-Techne price target raised to $285 from $265 at SVB Leerink
08/04/20 Craig-Hallum
Craig-Hallum upgrades Bio-Techne on 'powerful, long-term trend'
08/04/20 Craig-Hallum
Bio-Techne upgraded to Buy from Hold at Craig-Hallum
07/15/20 Stephens
Bio-Techne downgraded to Equal Weight from Overweight at Stephens
NVRO Nevro
$138.42 /

+3.64 (+2.70%)

09/01/20 Baird
Nevro initiated with an Outperform at Baird
08/06/20 SVB Leerink
Nevro price target raised to $165 from $140 at SVB Leerink
08/06/20 Wells Fargo
Nevro price target raised to $153 from $141 at Wells Fargo
08/06/20 Citi
Nevro price target raised to $160 from $137 at Citi
SUPN Supernus
$21.14 /

+0.28 (+1.34%)

06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
06/15/20 Jefferies
Supernus resumed with a Hold at Jefferies
04/30/20 Piper Sandler
Supernus price target raised to $25 from $17 at Piper Sandler
11/08/19 Berenberg
Supernus downgraded to Hold from Buy at Berenberg
NARI Inari Medical
$71.01 /

+1.29 (+1.85%)

08/12/20 Morgan Stanley
Inari Medical price target raised to $66 from $52 at Morgan Stanley
08/12/20 Canaccord
Inari Medical price target raised to $73 from $60 at Canaccord
06/19/20 Canaccord
Inari Medical initiated with a Buy at Canaccord
06/16/20 Morgan Stanley
Inari Medical initiated with an Equal Weight at Morgan Stanley
KZR Kezar Life Sciences
$4.64 /

-0.06 (-1.28%)

06/04/20 H.C. Wainwright
Kezar Life Sciences price target raised to $12 from $9 at H.C. Wainwright
05/05/20 H.C. Wainwright
Kezar Life Sciences price target lowered to $9 from $15 at H.C. Wainwright
HOLX Hologic
$59.21 /

+1.58 (+2.74%)

08/27/20 Morgan Stanley
Abbott 'may change the game' in COVID testing with BinaxNOW, says Morgan Stanley
07/30/20 Needham
Hologic price target raised to $78 from $64 at Needham
07/30/20 Wells Fargo
Hologic price target raised to $80 from $63 at Wells Fargo
07/30/20 BTIG
Hologic price target raised to $84 from $63 at BTIG
MYOK MyoKardia
$110.51 /

+3.205 (+2.99%)

09/01/20 Cantor Fitzgerald
MyoKardia data looks 'practice changing' for oHCM, says Cantor Fitzgerald
05/20/20 Cantor Fitzgerald
MyoKardia price target raised to $188 from $95 at Cantor Fitzgerald
05/14/20 BMO Capital
MyoKardia price target raised to $148 from $90 at BMO Capital
05/12/20 Citi
MyoKardia takeout value in $160 to $190 per share range, says Citi
PINC Premier
$32.60 /

+0.42 (+1.31%)

08/31/20
Fly Intel: Top five analyst upgrades
08/31/20 Guggenheim
Premier upgraded to Buy from Neutral at Guggenheim
08/26/20
Fly Intel: Top five analyst downgrades
08/26/20 Benchmark
Premier downgraded to Hold from Buy at Benchmark
UHS Universal Health
$111.30 /

+1.98 (+1.81%)

06/09/20 Barclays
Barclays upgrades Universal Health on higher mental health demand
06/09/20 Barclays
Universal Health upgraded to Overweight from Equal Weight at Barclays
05/29/20 Mizuho
Universal Health price target lowered to $130 from $136 at Mizuho
04/29/20 Deutsche Bank
Universal Health price target lowered to $135 from $165 at Deutsche Bank
JNCE Jounce Therapeutics
$7.89 /

+0.42 (+5.62%)

09/02/20 Roth Capital
Rapt rise after Gilead deal with Jounce 'warranted,' says Roth Capital
09/02/20 H.C. Wainwright
Jounce Therapeutics price target raised to $9 from $8 at H.C. Wainwright
05/07/20 H.C. Wainwright
Jounce Therapeutics price target lowered to $8 from $10 at H.C. Wainwright
03/25/20 Raymond James
Jounce upgraded to Strong Buy ahead of cancer data at Raymond James
JNJ Johnson & Johnson
$149.80 /

+2.56 (+1.74%)

09/01/20 Morgan Stanley
Catalent has potential upside from COVID vaccine, says Morgan Stanley
08/25/20 H.C. Wainwright
Momenta downgraded to Neutral from Buy at H.C. Wainwright
08/24/20 Raymond James
Momenta initiated with a Market Perform at Raymond James
08/24/20 Raymond James
Argenx initiated with an Outperform at Raymond James
GBT Global Blood Therapeutics
$57.82 /

-0.92 (-1.57%)

08/25/20 Wedbush
Global Blood Therapeutics price target raised to $152 from $145 at Wedbush
08/24/20 Raymond James
Global Blood Therapeutics initiated with an Outperform at Raymond James
07/20/20 Roth Capital
Global Blood Therapeutics initiated with a Buy at Roth Capital
07/13/20 BofA
Global Blood Therapeutics initiated with a Buy at BofA
MDT Medtronic
$106.65 /

+2.18 (+2.09%)

08/26/20 Raymond James
Medtronic price target raised to $115 from $107 at Raymond James
08/26/20 BTIG
Medtronic price target raised to $111 from $102 at BTIG
08/26/20 Citi
Medtronic price target raised to $120 from $108 at Citi
08/25/20 Piper Sandler
Medtronic outlook commentary 'read positively,' says Piper Sandler
RNA Avidity Biosciences
$33.12 /

+2.73 (+8.98%)

07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 SVB Leerink
Avidity Biosciences initiated with an Outperform at SVB Leerink
07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 Wells Fargo
Avidity Biosciences initiated with an Overweight at Wells Fargo
SEM Select Medical
$19.92 /

+0.16 (+0.81%)

08/04/20 Deutsche Bank
Select Medical price target raised to $26 from $24 at Deutsche Bank
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
05/04/20 Wells Fargo
Select Medical price target lowered to $24 from $31 at Wells Fargo
ZYME Zymeworks
$31.46 /

+0.225 (+0.72%)

UHS Universal Health
$111.30 /

+1.98 (+1.81%)

TFX Teleflex
$389.99 /

+7.865 (+2.06%)

TECH Bio-Techne
$250.24 /

+4.44 (+1.81%)

TCON Tracon Pharmaceuticals
$3.56 /

-0.18 (-4.81%)

SUPN Supernus
$21.14 /

+0.28 (+1.34%)

SEM Select Medical
$19.92 /

+0.16 (+0.81%)

RNA Avidity Biosciences
$33.12 /

+2.73 (+8.98%)

PINC Premier
$32.60 /

+0.42 (+1.31%)

NVRO Nevro
$138.42 /

+3.64 (+2.70%)

NARI Inari Medical
$71.01 /

+1.29 (+1.85%)

MYOK MyoKardia
$110.51 /

+3.205 (+2.99%)

MDT Medtronic
$106.65 /

+2.18 (+2.09%)

KZR Kezar Life Sciences
$4.64 /

-0.06 (-1.28%)

JNJ Johnson & Johnson
$149.80 /

+2.56 (+1.74%)

JNCE Jounce Therapeutics
$7.89 /

+0.42 (+5.62%)

IRWD Ironwood
$9.88 /

+0.17 (+1.75%)

INSP Inspire Medical
$120.82 /

+3.19 (+2.71%)

IMMU Acquired by GILD
$42.25 /

+1.71 (+4.22%)

ICPT Intercept
$44.54 /

+0.53 (+1.20%)

ICLR Icon
$180.39 /

+3.92 (+2.22%)

HOLX Hologic
$59.21 /

+1.58 (+2.74%)

HALO Halozyme
$28.04 /

+0.29 (+1.05%)

GBT Global Blood Therapeutics
$57.82 /

-0.92 (-1.57%)

BLCM Bellicum Pharmaceuticals
$5.33 /

+0.11 (+2.11%)

  • 18
    Aug
  • 09
    Jun
  • 12
    Jun
  • 22
    May
  • 13
    May
  • 29
    Apr
  • 14
    Apr
  • 02
    Apr
  • 31
    Jan
  • 23
    Jan
  • 05
    Dec
  • 12
    Sep
UHS Universal Health
$111.30 /

+1.98 (+1.81%)

MDT Medtronic
$106.65 /

+2.18 (+2.09%)

JNJ Johnson & Johnson
$149.80 /

+2.56 (+1.74%)

INSP Inspire Medical
$120.82 /

+3.19 (+2.71%)

IMMU Acquired by GILD
$42.25 /

+1.71 (+4.22%)

UHS Universal Health
$111.30 /

+1.98 (+1.81%)

SUPN Supernus
$21.14 /

+0.28 (+1.34%)

RNA Avidity Biosciences
$33.12 /

+2.73 (+8.98%)

NVRO Nevro
$138.42 /

+3.64 (+2.70%)

NARI Inari Medical
$71.01 /

+1.29 (+1.85%)

MYOK MyoKardia
$110.51 /

+3.205 (+2.99%)

MDT Medtronic
$106.65 /

+2.18 (+2.09%)

KZR Kezar Life Sciences
$4.64 /

-0.06 (-1.28%)

JNJ Johnson & Johnson
$149.80 /

+2.56 (+1.74%)

IRWD Ironwood
$9.88 /

+0.17 (+1.75%)

INSP Inspire Medical
$120.82 /

+3.19 (+2.71%)

IMMU Acquired by GILD
$42.25 /

+1.71 (+4.22%)

ICPT Intercept
$44.54 /

+0.53 (+1.20%)

HOLX Hologic
$59.21 /

+1.58 (+2.74%)

HALO Halozyme
$28.04 /

+0.29 (+1.05%)

GBT Global Blood Therapeutics
$57.82 /

-0.92 (-1.57%)

UHS Universal Health
$111.30 /

+1.98 (+1.81%)

NARI Inari Medical
$71.01 /

+1.29 (+1.85%)

MDT Medtronic
$106.65 /

+2.18 (+2.09%)

KZR Kezar Life Sciences
$4.64 /

-0.06 (-1.28%)

JNJ Johnson & Johnson
$149.80 /

+2.56 (+1.74%)

IMMU Acquired by GILD
$42.25 /

+1.71 (+4.22%)

HOLX Hologic
$59.21 /

+1.58 (+2.74%)

BLCM Bellicum Pharmaceuticals
$5.33 /

+0.11 (+2.11%)

Conference/Events
Wells Fargo to hold a virtual conference » 08:21
09/09/20
09/09
08:21
09/09/20
08:21
INSP

Inspire Medical

$117.72 /

-0.48 (-0.41%)

, ICLR

Icon

$176.59 /

-1.51 (-0.85%)

, IMMU

Acquired by GILD

$40.54 /

-1.4 (-3.34%)

, CYAD

Celyad

$9.99 /

+ (+0.00%)

, HALO

Halozyme

$27.75 /

+0.05 (+0.18%)

, TCON

Tracon Pharmaceuticals

$3.74 /

+0.64 (+20.65%)

, ZYME

Zymeworks

$31.24 /

-0.475 (-1.50%)

, IRWD

Ironwood

$9.71 /

-0.07 (-0.72%)

, ICPT

Intercept

$44.01 /

-1.32 (-2.91%)

, BLCM

Bellicum Pharmaceuticals

$5.24 /

+0.1 (+1.95%)

, TFX

Teleflex

$381.68 /

-8.105 (-2.08%)

, TECH

Bio-Techne

$245.83 /

-0.47 (-0.19%)

, NVRO

Nevro

$134.78 /

-2.27 (-1.66%)

, SUPN

Supernus

$20.86 /

-0.62 (-2.89%)

, NARI

Inari Medical

$69.72 /

-0.78 (-1.11%)

, KZR

Kezar Life Sciences

$4.67 /

+0.05 (+1.08%)

, HOLX

Hologic

$57.63 /

-0.66 (-1.13%)

, MYOK

MyoKardia

$107.40 /

-5.82 (-5.14%)

, PINC

Premier

$32.18 /

-0.31 (-0.95%)

, UHS

Universal Health

$109.32 /

-4.21 (-3.71%)

, JNCE

Jounce Therapeutics

$7.45 /

+0.75 (+11.19%)

, JNJ

Johnson & Johnson

$147.24 /

-1.33 (-0.90%)

, GBT

Global Blood Therapeutics

$58.74 /

-0.37 (-0.63%)

, MDT

Medtronic

$104.47 /

-1.32 (-1.25%)

, RNA

Avidity Biosciences

$30.39 /

+1.55 (+5.37%)

, SEM

Select Medical

$19.76 /

-0.515 (-2.54%)

Healthcare Virtual…

Healthcare Virtual Conference will be held on September 9-10. Webcast Link

ShowHide Related Items >><<
ZYME Zymeworks
$31.24 /

-0.475 (-1.50%)

UHS Universal Health
$109.32 /

-4.21 (-3.71%)

TFX Teleflex
$381.68 /

-8.105 (-2.08%)

TECH Bio-Techne
$245.83 /

-0.47 (-0.19%)

TCON Tracon Pharmaceuticals
$3.74 /

+0.64 (+20.65%)

SUPN Supernus
$20.86 /

-0.62 (-2.89%)

SEM Select Medical
$19.76 /

-0.515 (-2.54%)

RNA Avidity Biosciences
$30.39 /

+1.55 (+5.37%)

PINC Premier
$32.18 /

-0.31 (-0.95%)

NVRO Nevro
$134.78 /

-2.27 (-1.66%)

MYOK MyoKardia
$107.40 /

-5.82 (-5.14%)

MDT Medtronic
$104.47 /

-1.32 (-1.25%)

KZR Kezar Life Sciences
$4.67 /

+0.05 (+1.08%)

JNJ Johnson & Johnson
$147.24 /

-1.33 (-0.90%)

JNCE Jounce Therapeutics
$7.45 /

+0.75 (+11.19%)

IRWD Ironwood
$9.71 /

-0.07 (-0.72%)

INSP Inspire Medical
$117.72 /

-0.48 (-0.41%)

IMMU Acquired by GILD
$40.54 /

-1.4 (-3.34%)

ICPT Intercept
$44.01 /

-1.32 (-2.91%)

ICLR Icon
$176.59 /

-1.51 (-0.85%)

HOLX Hologic
$57.63 /

-0.66 (-1.13%)

HALO Halozyme
$27.75 /

+0.05 (+0.18%)

GBT Global Blood Therapeutics
$58.74 /

-0.37 (-0.63%)

CYAD Celyad
$9.99 /

+ (+0.00%)

BLCM Bellicum Pharmaceuticals
$5.24 /

+0.1 (+1.95%)

INSP Inspire Medical
$117.72 /

-0.48 (-0.41%)

09/01/20 Baird
Inspire Medical initiated with an Outperform at Baird
08/21/20 Stifel
Inspire Medical price target raised to $125 from $110 at Stifel
08/06/20 Wells Fargo
Inspire Medical price target raised to $125 from $115 at Wells Fargo
08/06/20 BofA
Inspire Medical downgraded to Neutral from Buy at BofA
ICLR Icon
$176.59 /

-1.51 (-0.85%)

07/27/20 Truist
SunTrust raises price targets on select late-stage CROs
07/27/20 Deutsche Bank
Icon price target raised to $170 from $135 at Deutsche Bank
07/27/20 Mizuho
Icon price target raised to $195 from $170 at Mizuho
07/24/20 BofA
Icon downgraded to Neutral from Buy at BofA
IMMU Acquired by GILD
$40.54 /

-1.4 (-3.34%)

08/17/20 Cowen
Immunomedics should have sufficient capacity to supply Trodelvy, says Cowen
08/05/20 Piper Sandler
Immunomedics price target raised to $60 from $55 at Piper Sandler
08/03/20 Piper Sandler
Immunomedics launch looks 'very favorable,' says Piper Sandler
07/27/20 Jefferies
Immunomedics price target raised to $55 after doctor survey at Jefferies
CYAD Celyad
$9.99 /

+ (+0.00%)

03/26/20 Wells Fargo
Celyad price target lowered to $20 from $44 at Wells Fargo
03/25/20 H.C. Wainwright
Celyad price target lowered to $37 from $43 at H.C. Wainwright
HALO Halozyme
$27.75 /

+0.05 (+0.18%)

08/11/20 BMO Capital
Halozyme price target raised to $43 from $35 at BMO Capital
08/11/20 Wells Fargo
Halozyme price target raised to $39 from $31 at Wells Fargo
07/02/20 Piper Sandler
Halozyme price target raised to $31 from $28 at Piper Sandler
07/01/20 Benchmark
Benchmark starts Halozyme at Buy with $39 price target
TCON Tracon Pharmaceuticals
$3.74 /

+0.64 (+20.65%)

04/24/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $4 from $6 at H.C. Wainwright
03/10/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $6 from $13 at H.C. Wainwright
02/28/20 H.C. Wainwright
Tracon Pharmaceuticals price target lowered to $13 from $18 at H.C. Wainwright
12/23/19 H.C. Wainwright
Tracon Pharmaceuticals price target raised to $18 from $15 at H.C. Wainwright
ZYME Zymeworks
$31.24 /

-0.475 (-1.50%)

08/06/20
Fly Intel: Top analyst initiations
08/06/20 SVB Leerink
SVB Leerink bullish on Zymeworks, initiates with an Outperform
08/06/20 SVB Leerink
Zymeworks initiated with an Outperform at SVB Leerink
07/14/20 Guggenheim
Zymeworks price target lowered to $48, removed as Best Idea at Guggenheim
IRWD Ironwood
$9.71 /

-0.07 (-0.72%)

06/17/20 Northland
Northland starts Ironwood at Outperform, sees long runway for Linzess
06/17/20 Northland
Ironwood initiated with an Outperform at Northland
ICPT Intercept
$44.01 /

-1.32 (-2.91%)

09/02/20 Piper Sandler
Intercept workforce cut not related to potential approval, says Piper Sandler
08/28/20 Piper Sandler
Piper says Intercept data continues to tilt risk/benefit argument raised in CRL
08/27/20 Piper Sandler
Intercept's OCA 'comes out on top' at EASL, says Piper Sandler
08/10/20 Stifel
Intercept price target raised to $56 from $51 at Stifel
BLCM Bellicum Pharmaceuticals
$5.24 /

+0.1 (+1.95%)

03/13/20 Raymond James
Bellicum Pharmaceuticals price target lowered to $17 from $40 at Raymond James
02/14/20 Wells Fargo
Bellicum Pharmaceuticals price target raised to $18 from $4 at Wells Fargo
01/24/20 Ladenburg
Bellicum pancreatic cancer data showed 'robust expansion,' says Ladenburg
TFX Teleflex
$381.68 /

-8.105 (-2.08%)

08/03/20 Piper Sandler
Teleflex approval for Urolift 2 earlier than expected, says Piper Sandler
07/30/20 Piper Sandler
Teleflex selloff on DOJ investigation should be bought, says Piper Sandler
06/09/20 Wells Fargo
Teleflex price target raised to $425 from $375 at Wells Fargo
06/04/20 SVB Leerink
Teleflex price target raised to $425 from $400 at SVB Leerink
TECH Bio-Techne
$245.83 /

-0.47 (-0.19%)

08/05/20 SVB Leerink
Bio-Techne price target raised to $285 from $265 at SVB Leerink
08/04/20 Craig-Hallum
Craig-Hallum upgrades Bio-Techne on 'powerful, long-term trend'
08/04/20 Craig-Hallum
Bio-Techne upgraded to Buy from Hold at Craig-Hallum
07/15/20 Stephens
Bio-Techne downgraded to Equal Weight from Overweight at Stephens
NVRO Nevro
$134.78 /

-2.27 (-1.66%)

09/01/20 Baird
Nevro initiated with an Outperform at Baird
08/06/20 SVB Leerink
Nevro price target raised to $165 from $140 at SVB Leerink
08/06/20 Wells Fargo
Nevro price target raised to $153 from $141 at Wells Fargo
08/06/20 Citi
Nevro price target raised to $160 from $137 at Citi
SUPN Supernus
$20.86 /

-0.62 (-2.89%)

06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
06/15/20 Jefferies
Supernus resumed with a Hold at Jefferies
04/30/20 Piper Sandler
Supernus price target raised to $25 from $17 at Piper Sandler
11/08/19 Berenberg
Supernus downgraded to Hold from Buy at Berenberg
NARI Inari Medical
$69.72 /

-0.78 (-1.11%)

08/12/20 Morgan Stanley
Inari Medical price target raised to $66 from $52 at Morgan Stanley
08/12/20 Canaccord
Inari Medical price target raised to $73 from $60 at Canaccord
06/19/20 Canaccord
Inari Medical initiated with a Buy at Canaccord
06/16/20 Morgan Stanley
Inari Medical initiated with an Equal Weight at Morgan Stanley
KZR Kezar Life Sciences
$4.67 /

+0.05 (+1.08%)

06/04/20 H.C. Wainwright
Kezar Life Sciences price target raised to $12 from $9 at H.C. Wainwright
05/05/20 H.C. Wainwright
Kezar Life Sciences price target lowered to $9 from $15 at H.C. Wainwright
HOLX Hologic
$57.63 /

-0.66 (-1.13%)

08/27/20 Morgan Stanley
Abbott 'may change the game' in COVID testing with BinaxNOW, says Morgan Stanley
07/30/20 Needham
Hologic price target raised to $78 from $64 at Needham
07/30/20 Wells Fargo
Hologic price target raised to $80 from $63 at Wells Fargo
07/30/20 BTIG
Hologic price target raised to $84 from $63 at BTIG
MYOK MyoKardia
$107.40 /

-5.82 (-5.14%)

09/01/20 Cantor Fitzgerald
MyoKardia data looks 'practice changing' for oHCM, says Cantor Fitzgerald
05/20/20 Cantor Fitzgerald
MyoKardia price target raised to $188 from $95 at Cantor Fitzgerald
05/14/20 BMO Capital
MyoKardia price target raised to $148 from $90 at BMO Capital
05/12/20 Citi
MyoKardia takeout value in $160 to $190 per share range, says Citi
PINC Premier
$32.18 /

-0.31 (-0.95%)

08/31/20
Fly Intel: Top five analyst upgrades
08/31/20 Guggenheim
Premier upgraded to Buy from Neutral at Guggenheim
08/26/20
Fly Intel: Top five analyst downgrades
08/26/20 Benchmark
Premier downgraded to Hold from Buy at Benchmark
UHS Universal Health
$109.32 /

-4.21 (-3.71%)

06/09/20 Barclays
Barclays upgrades Universal Health on higher mental health demand
06/09/20 Barclays
Universal Health upgraded to Overweight from Equal Weight at Barclays
05/29/20 Mizuho
Universal Health price target lowered to $130 from $136 at Mizuho
04/29/20 Deutsche Bank
Universal Health price target lowered to $135 from $165 at Deutsche Bank
JNCE Jounce Therapeutics
$7.45 /

+0.75 (+11.19%)

09/02/20 Roth Capital
Rapt rise after Gilead deal with Jounce 'warranted,' says Roth Capital
09/02/20 H.C. Wainwright
Jounce Therapeutics price target raised to $9 from $8 at H.C. Wainwright
05/07/20 H.C. Wainwright
Jounce Therapeutics price target lowered to $8 from $10 at H.C. Wainwright
03/25/20 Raymond James
Jounce upgraded to Strong Buy ahead of cancer data at Raymond James
JNJ Johnson & Johnson
$147.24 /

-1.33 (-0.90%)

09/01/20 Morgan Stanley
Catalent has potential upside from COVID vaccine, says Morgan Stanley
08/25/20 H.C. Wainwright
Momenta downgraded to Neutral from Buy at H.C. Wainwright
08/24/20 Raymond James
Momenta initiated with a Market Perform at Raymond James
08/24/20 Raymond James
Argenx initiated with an Outperform at Raymond James
GBT Global Blood Therapeutics
$58.74 /

-0.37 (-0.63%)

08/25/20 Wedbush
Global Blood Therapeutics price target raised to $152 from $145 at Wedbush
08/24/20 Raymond James
Global Blood Therapeutics initiated with an Outperform at Raymond James
07/20/20 Roth Capital
Global Blood Therapeutics initiated with a Buy at Roth Capital
07/13/20 BofA
Global Blood Therapeutics initiated with a Buy at BofA
MDT Medtronic
$104.47 /

-1.32 (-1.25%)

08/26/20 Raymond James
Medtronic price target raised to $115 from $107 at Raymond James
08/26/20 BTIG
Medtronic price target raised to $111 from $102 at BTIG
08/26/20 Citi
Medtronic price target raised to $120 from $108 at Citi
08/25/20 Piper Sandler
Medtronic outlook commentary 'read positively,' says Piper Sandler
RNA Avidity Biosciences
$30.39 /

+1.55 (+5.37%)

07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 SVB Leerink
Avidity Biosciences initiated with an Outperform at SVB Leerink
07/07/20 Cowen
Avidity Biosciences initiated with an Outperform at Cowen
07/07/20 Wells Fargo
Avidity Biosciences initiated with an Overweight at Wells Fargo
SEM Select Medical
$19.76 /

-0.515 (-2.54%)

08/04/20 Deutsche Bank
Select Medical price target raised to $26 from $24 at Deutsche Bank
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
05/04/20 Wells Fargo
Select Medical price target lowered to $24 from $31 at Wells Fargo
ZYME Zymeworks
$31.24 /

-0.475 (-1.50%)

UHS Universal Health
$109.32 /

-4.21 (-3.71%)

TFX Teleflex
$381.68 /

-8.105 (-2.08%)

TECH Bio-Techne
$245.83 /

-0.47 (-0.19%)

TCON Tracon Pharmaceuticals
$3.74 /

+0.64 (+20.65%)

SUPN Supernus
$20.86 /

-0.62 (-2.89%)

SEM Select Medical
$19.76 /

-0.515 (-2.54%)

RNA Avidity Biosciences
$30.39 /

+1.55 (+5.37%)

PINC Premier
$32.18 /

-0.31 (-0.95%)

NVRO Nevro
$134.78 /

-2.27 (-1.66%)

NARI Inari Medical
$69.72 /

-0.78 (-1.11%)

MYOK MyoKardia
$107.40 /

-5.82 (-5.14%)

MDT Medtronic
$104.47 /

-1.32 (-1.25%)

KZR Kezar Life Sciences
$4.67 /

+0.05 (+1.08%)

JNJ Johnson & Johnson
$147.24 /

-1.33 (-0.90%)

JNCE Jounce Therapeutics
$7.45 /

+0.75 (+11.19%)

IRWD Ironwood
$9.71 /

-0.07 (-0.72%)

INSP Inspire Medical
$117.72 /

-0.48 (-0.41%)

IMMU Acquired by GILD
$40.54 /

-1.4 (-3.34%)

ICPT Intercept
$44.01 /

-1.32 (-2.91%)

ICLR Icon
$176.59 /

-1.51 (-0.85%)

HOLX Hologic
$57.63 /

-0.66 (-1.13%)

HALO Halozyme
$27.75 /

+0.05 (+0.18%)

GBT Global Blood Therapeutics
$58.74 /

-0.37 (-0.63%)

BLCM Bellicum Pharmaceuticals
$5.24 /

+0.1 (+1.95%)

  • 18
    Aug
  • 09
    Jun
  • 12
    Jun
  • 22
    May
  • 13
    May
  • 29
    Apr
  • 14
    Apr
  • 02
    Apr
  • 31
    Jan
  • 23
    Jan
  • 05
    Dec
  • 12
    Sep
UHS Universal Health
$109.32 /

-4.21 (-3.71%)

MDT Medtronic
$104.47 /

-1.32 (-1.25%)

JNJ Johnson & Johnson
$147.24 /

-1.33 (-0.90%)

INSP Inspire Medical
$117.72 /

-0.48 (-0.41%)

IMMU Acquired by GILD
$40.54 /

-1.4 (-3.34%)

UHS Universal Health
$109.32 /

-4.21 (-3.71%)

SUPN Supernus
$20.86 /

-0.62 (-2.89%)

RNA Avidity Biosciences
$30.39 /

+1.55 (+5.37%)

NVRO Nevro
$134.78 /

-2.27 (-1.66%)

NARI Inari Medical
$69.72 /

-0.78 (-1.11%)

MYOK MyoKardia
$107.40 /

-5.82 (-5.14%)

MDT Medtronic
$104.47 /

-1.32 (-1.25%)

KZR Kezar Life Sciences
$4.67 /

+0.05 (+1.08%)

JNJ Johnson & Johnson
$147.24 /

-1.33 (-0.90%)

IRWD Ironwood
$9.71 /

-0.07 (-0.72%)

INSP Inspire Medical
$117.72 /

-0.48 (-0.41%)

IMMU Acquired by GILD
$40.54 /

-1.4 (-3.34%)

ICPT Intercept
$44.01 /

-1.32 (-2.91%)

HOLX Hologic
$57.63 /

-0.66 (-1.13%)

HALO Halozyme
$27.75 /

+0.05 (+0.18%)

GBT Global Blood Therapeutics
$58.74 /

-0.37 (-0.63%)

UHS Universal Health
$109.32 /

-4.21 (-3.71%)

NARI Inari Medical
$69.72 /

-0.78 (-1.11%)

MDT Medtronic
$104.47 /

-1.32 (-1.25%)

KZR Kezar Life Sciences
$4.67 /

+0.05 (+1.08%)

JNJ Johnson & Johnson
$147.24 /

-1.33 (-0.90%)

IMMU Acquired by GILD
$40.54 /

-1.4 (-3.34%)

HOLX Hologic
$57.63 /

-0.66 (-1.13%)

BLCM Bellicum Pharmaceuticals
$5.24 /

+0.1 (+1.95%)

Over a quarter ago
Recommendations
Select Medical price target raised to $26 from $24 at Deutsche Bank » 07:52
08/04/20
08/04
07:52
08/04/20
07:52
SEM

Select Medical

$18.98 /

-0.05 (-0.26%)

Deutsche Bank analyst…

Deutsche Bank analyst Justin Bowers raised the firm's price target on Select Medical to $26 from $24 and keeps a Buy rating on the shares. The analyst increased his previously Street high estimates following Select's Q2 beat and is "incrementally positive," seeing a "sustainable upward trajectory" in the inpatient businesses in the near-term and beyond 2020. The analyst views Select Medical as one of the most attractive risk/rewards among his SMID cap universe.

ShowHide Related Items >><<
SEM Select Medical
$18.98 /

-0.05 (-0.26%)

SEM Select Medical
$18.98 /

-0.05 (-0.26%)

06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
05/04/20 Wells Fargo
Select Medical price target lowered to $24 from $31 at Wells Fargo
05/04/20 Deutsche Bank
Select Medical selloff Friday 'misaligned' with results, says Deutsche Bank
SEM Select Medical
$18.98 /

-0.05 (-0.26%)

Hot Stocks
Select Medical announces $500M share repurchase program » 16:43
07/30/20
07/30
16:43
07/30/20
16:43
SEM

Select Medical

$16.80 /

-0.04 (-0.24%)

The board of directors of…

The board of directors of Select Medical has authorized a common stock repurchase program to repurchase up to $500M worth of shares of its common stock. The program has been extended until December 31, 2020, and will remain in effect until then, unless further extended or earlier terminated by the board of directors.

ShowHide Related Items >><<
SEM Select Medical
$16.80 /

-0.04 (-0.24%)

SEM Select Medical
$16.80 /

-0.04 (-0.24%)

06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
05/04/20 Wells Fargo
Select Medical price target lowered to $24 from $31 at Wells Fargo
05/04/20 Deutsche Bank
Select Medical selloff Friday 'misaligned' with results, says Deutsche Bank
SEM Select Medical
$16.80 /

-0.04 (-0.24%)

Earnings
Select Medical reports Q2 adjusted EPS 38c, consensus 2c » 16:42
07/30/20
07/30
16:42
07/30/20
16:42
SEM

Select Medical

$16.80 /

-0.04 (-0.24%)

Reports Q2 revenue…

Reports Q2 revenue $1.23B, consensus $1.15B.

ShowHide Related Items >><<
SEM Select Medical
$16.80 /

-0.04 (-0.24%)

SEM Select Medical
$16.80 /

-0.04 (-0.24%)

06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
05/04/20 Wells Fargo
Select Medical price target lowered to $24 from $31 at Wells Fargo
05/04/20 Deutsche Bank
Select Medical selloff Friday 'misaligned' with results, says Deutsche Bank
SEM Select Medical
$16.80 /

-0.04 (-0.24%)

Downgrade
Select Medical downgraded to Underperform from Neutral at BofA » 06:18
06/16/20
06/16
06:18
06/16/20
06:18
SEM

Select Medical

$16.21 /

+0.51 (+3.25%)

BofA analyst Kevin…

BofA analyst Kevin Fischbeck downgraded Select Medical to Underperform from Neutral with a price target of $15, down from $18. The analyst sees little upside into 2021 given that a little over half of Select Medical's EBITDA is from businesses with above average exposure to COVID-19 and a recession. Fischbeck believes there is a risk of a second wave in COVID-19, either in the near-term as states reopen, or in the Fall if COVID-19 follows the trajectory of other pandemics, but the market does not appear to be discounting this risk, and he is concerned that the impact could be longer lasting for Select Medical.

ShowHide Related Items >><<
SEM Select Medical
$16.21 /

+0.51 (+3.25%)

SEM Select Medical
$16.21 /

+0.51 (+3.25%)

06/16/20 BofA
Select Medical downgraded to Underperform from Neutral at BofA
05/04/20 Wells Fargo
Select Medical price target lowered to $24 from $31 at Wells Fargo
05/04/20 Deutsche Bank
Select Medical selloff Friday 'misaligned' with results, says Deutsche Bank
02/24/20 RBC Capital
Select Medical price target raised to $32 from $27 at RBC Capital
SEM Select Medical
$16.21 /

+0.51 (+3.25%)

Downgrade
Select Medical downgraded to Underperform from Neutral at BofA » 06:05
06/16/20
06/16
06:05
06/16/20
06:05
SEM

Select Medical

$16.21 /

+0.51 (+3.25%)

BofA downgraded Select…

BofA downgraded Select Medical to Underperform from Neutral.

ShowHide Related Items >><<
SEM Select Medical
$16.21 /

+0.51 (+3.25%)

SEM Select Medical
$16.21 /

+0.51 (+3.25%)

05/04/20 Wells Fargo
Select Medical price target lowered to $24 from $31 at Wells Fargo
05/04/20 Deutsche Bank
Select Medical selloff Friday 'misaligned' with results, says Deutsche Bank
02/24/20 RBC Capital
Select Medical price target raised to $32 from $27 at RBC Capital
01/28/20 RBC Capital
Select Medical price target raised to $27 from $21 at RBC Capital
SEM Select Medical
$16.21 /

+0.51 (+3.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.